Innovative Alkanediol-Based Eutectic Solvents for Extracting/Pre-Formulating Dermatologically Valuable Free Fatty Acids from Spirulina and Porphyridium Cakes
Marine Drugs · 15.06.2024 · 22 (6) · 281
DOI: 10.3390/md22060281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 15.06.2024. Verfasst von Laura Wils und 6 weiteren Autor:innen. Beteiligte Einrichtung: UR 7502 SIMBA, Faculté de Pharmacie, Université de Tours, 31 Avenue Monge, 37200 Tours, France. Hauptthemen laut MEDLINE: Spirulina, Fatty Acids, Nonesterified. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Conseil régional du Centre-Val de Loire, French National Research Agency.
Abstract (Originalsprache)
The growing demand for phycobiliproteins from microalgae generates a significant volume of by-products, such as extraction cakes. These cakes are enriched with products of interest for the cosmetics market, namely free fatty acids, particularly polyunsaturated (PUFA). In this work, two cakes, one of spirulina and one of Porphyridium cruentum, were valorized using innovative natural hydrophobic deep eutectic solvents (NaDES) based on alkanediols. The most promising NaDES, as determined by physicochemical properties and screening, are mixtures of alkanediols and fatty acids. These include the mixtures of 1,3-propanediol and octanoic acid (1:5, mol/mol) and 1,3-propanediol and octanoic and decanoic acid (1:3:1, mol/mol). Two extractive processes were implemented: ultrasound-assisted extraction and an innovative mechanical process involving dual asymmetric centrifugation. The second process resulted in the production of extracts significantly enriched in PUFA, ranging from 65 to 220 mg/g dry matter with the two cakes. The extracts and NaDES demonstrated good safety with respect to epidermal keratinocyte viability (>80% at 200 µg/mL). The study of their impact on commensal and pathogenic cutaneous bacteria demonstrated significant effects on the viability of Staphylococcus aureus and Staphylococcus epidermidis (>50% decrease at 200 µg/mL) while preserving Corynebacterium xerosis and Cutibacterium acnes. These results highlight the potential of valorizing these co-products using alkanediol-based NaDES, in a strategy combining an active vector (NaDES) and a growth regulator extract, for the management of cutaneous dysbiosis involving staphylococci.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UR 7502 SIMBA, Faculté de Pharmacie, Université de Tours, 31 Avenue Monge, 37200 Tours, France.
- Laboratoire Inflammation Tissus Epithéliaux et Cytokines (LITEC), Université de Poitiers, 86073 Poitiers, Cedex 9, France.
- Aqua Eco Culture, 7 Rue d'Armor Maroué, 22400 Lamballe, France.
ORCID-Profile: Laura Wils, Mervé Yagmur, Charles Bodet, Leslie Boudesocque-Delaye
Förderung
- Agence Nationale de la Recherche
- Conseil régional du Centre-Val de Loire
- French National Research Agency
- Région Centre Val de Loire
Zitieren
APA
Wils, L., Yagmur, M., Bellin, N., Phelippe, M., Chevalley, A., Bodet, C., & Boudesocque-Delaye, L. (2024). Innovative Alkanediol-Based Eutectic Solvents for Extracting/Pre-Formulating Dermatologically Valuable Free Fatty Acids from Spirulina and Porphyridium Cakes. Marine Drugs, 22(6), 281. https://doi.org/10.3390/md22060281
Vancouver
Wils L, Yagmur M, Bellin N, Phelippe M, Chevalley A, Bodet C, et al. Innovative Alkanediol-Based Eutectic Solvents for Extracting/Pre-Formulating Dermatologically Valuable Free Fatty Acids from Spirulina and Porphyridium Cakes. Marine Drugs. 2024;22(6):281. doi:10.3390/md22060281
BibTeX
@article{Wils2024,
author = {Wils, Laura and Yagmur, Mervé and Bellin, Nicolas and Phelippe, Myriam and Chevalley, Alia and Bodet, Charles and Boudesocque-Delaye, Leslie},
title = {Innovative Alkanediol-Based Eutectic Solvents for Extracting/Pre-Formulating Dermatologically Valuable Free Fatty Acids from Spirulina and Porphyridium Cakes},
journal = {Marine Drugs},
year = {2024},
volume = {22},
number = {6},
pages = {281},
doi = {10.3390/md22060281}
}
EUVIMED